OEM Analysis Method Establishing Manufacturer & Supplier in Spain

Precision Chromatographic Validation, Pharmacopoeial Compliance (Ph. Eur. / AEMPS), and Botanical CDMO Engineering Tailored for the Iberian Pharmaceutical and Nutraceutical Ecosystem.

Send Inquiry Now
Primary Solutions

Standardized Botanical Solutions for Spain & EU

Targeted analytical profiling, pharmacological screening, and clinical-grade verification platforms designed to fast-track market approval across European territories.

Regional Landscape

Navigating Spain’s Dynamic Bio-Pharma & Botanical Sector

A rigorous analytical approach aligned with the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) and European Pharmacopoeia (Ph. Eur.) specifications.

AEMPS & Ph. Eur. Compliance

Spain enforces stringent technical thresholds for natural medicines and food supplements. Establishing quantitative analytical methods (HPLC-DAD, LC-MS/MS) ensures your products fulfill legal criteria for heavy metals, residual solvents, pesticide residues, and consistent bioactive concentration as prescribed by AEMPS and AESAN.

Phytochemical Cluster Demands

Catalonia, the Valencian Community, and Madrid represent primary pharmaceutical production clusters in Southern Europe. Brand holders require third-party method validation to separate structural isomers, stabilize sensitive flavonoids, and identify batch variances across Mediterranean raw herbs and global imports.

Traceability & Adulteration Control

With increasing scrutiny over botanical authenticity, Spanish importers demand fingerprinting technologies (HPTLC chromatographic profiles) capable of detecting economic adulterants, species substitution, and seasonal chemical drift before formulation and packaging.

Method Engineering

Method Establishing Roadmap: From Raw Plant to Finished Assay

Our ISO/IEC 17025 and GMP-aligned experimental matrices eliminate the analytical ambiguities inherent to complex natural substances.

Development Stage Technical Objective Instrument Architecture Spanish / EU Regulatory Deliverables
Phase 1: Extraction & Profiling Optimization of solid-liquid matrix extraction, solvent recovery, polarity balancing Ultrasonic/Soxhlet, High-Resolution MS, TLC Screening Solvent residue profiling (ICH Q3C compliant) & chemical fingerprint map
Phase 2: Method Development Stationary phase selection, gradient elution kinetics, signal resolution of marker compounds UPLC, HPLC (UV-Vis / DAD / ELSD / RID), GC-FID/MS System suitability criteria, resolution factor (Rs > 1.5) confirmation
Phase 3: ICH Q2(R1) Validation Quantifying specificity, linearity, precision (repeatability & intermediate), accuracy, LOD/LOQ, robustness Multivariate Chemometric Platforms, Triple Quadrupole LC-MS Formal Method Validation Protocol & Summary Certificate for AEMPS dossier submission
Phase 4: Commercial Tech Transfer Cross-laboratory verification, pilot production assaying, long-term stability testing Stability Chambers (ICH Climate Zone II & IV), Automated Titrators Standard Operating Procedure (SOP in EN/ES), finished product release specifications
Efficiency & Scalability

China Supply Chain Resilience & Cost Economics for Spanish Brands

Bridging deep botanical cultivation resources with state-of-the-art analytical infrastructure to empower European private-label and CDMO clients.

14+
Years Dedicated Botanical R&D
300+
In-House Scientists & QC Analysts
400+
Validated Single-Herb Monographs
100%
Confidential Entrusted Manufacturing

Direct Source Sourcing Power

By operating directly at the hub of botanical raw materials in China, we eliminate intermediary trading costs while maintaining absolute control over geographic variance, harvesting periods, and botanical authenticity.

Full-Chain Pilot to Production

Our infrastructure seamlessly translates bench-scale analytical methods developed in the CRO laboratory into industrial-scale production at CDMO facilities, guaranteeing zero method deviation during batch scale-up.

Full Analytical Dossier Delivery

Every commercial batch supplied to Spain arrives with comprehensive chromatograms, calibration curves, recovery test reports, and COAs ready for inclusion in European regulatory notifications and internal audits.

Complete Portfolio

End-to-End CRO & CDMO Service Ecosystem

Explore our validated contract analytical and production capabilities, fully available for Spanish brand owners, pharmaceutical laboratories, and cosmetic pioneers.

Technical Clarifications

Frequently Asked Questions: Analytical Methods & OEM Supply for Spain

Specific guidance on regulatory registration, technical validation, cross-border sample shipping, and IP safeguards.

How do your analytical method establishment services comply with Spanish AEMPS and European Pharmacopoeia (Ph. Eur.) guidelines?
All analytical methods developed in our facilities strictly adhere to ICH Q2(R1) guidelines and are structured to satisfy Ph. Eur. requirements for identification, purity, and assay determination. When establishing a method for the Spanish market, we calibrate our limits of detection (LOD), limits of quantitation (LOQ), recovery percentages, and specificity tests against applicable monographs. This makes the resulting documentation ready for direct submission in European Marketing Authorization or Mutual Recognition dossiers.
Can you assist Spanish nutraceutical companies with non-pharmacopoeial or novel botanicals?
Yes. For rare herbs, traditional Asian formulas, or novel botanical extractions where no official Ph. Eur. or Spanish National Formulary monograph exists, we engineer secondary reference standards and chromatographic fingerprints. We isolate active fractions, verify molecular structure via LC-MS/NMR, and design proprietary reverse-phase HPLC or GC methods with complete validation data (linearity, precision, robustness).
What is the standard procedure and timeline for cross-laboratory method transfer to our facilities in Spain?
Our technical transfer protocol comprises four structured steps: (1) Bilateral review of target instruments and column specifications between our Changsha laboratory and your Spanish facility; (2) Dispatch of reference substances, sample extracts, and detailed English/Spanish operating procedures; (3) Parallel execution of system suitability and repeatability assays; (4) Issuance of a joint Method Transfer Report. Typical turnaround for complete transfer ranges between 3 to 6 weeks.
How does MedGence handle intellectual property (IP) and confidential proprietary formulations?
We operate strictly under internationally binding Non-Disclosure Agreements (NDAs). All proprietary botanical fractions, extraction parameters, and analytical protocols established under contract research remain the exclusive intellectual property of the commissioning client. Our production lines maintain segregated batch control to ensure formula isolation and absolute data confidentiality.
What finished dosage forms and delivery options can be supplied to Madrid, Barcelona, or Valencia?
We support intermediate active ingredients (dry extract powders, viscous resins, essential oils, spray-dried granules) and finished formulations (hard gelatin/vegetarian capsules, film-coated tablets, oral liquids, softgels). Shipments to Spain are routed through authorized air freight or maritime cold-chain carriers with full customs clearance support, phytosanitary certificates, and import-ready batch release documentation.

Scale Your Botanical Project with Validated Precision

Connect with our senior analytical chemists and CDMO engineering team today to establish custom testing methods, validate botanical markers, or request a complete OEM technical consultation for the Spain market.

Send Inquiry Now